Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Biocytogen Pharmaceuticals announced the grand opening of a new 37,000 square foot facility in Waltham, MA for its US-based subsidiary, Biocytogen Boston Corporation.
read more
Thursday, August 17, 2023
The National Institutes of Health (NIH), the US’s medical research agency, selected Exothera S.A., a full-service Contract Development and Manufacturing Organization (CDMO) specialized in gene therapy, vaccines, oncolytic viruses, and nucleic acid-...
read more
Bios Health Group entered into the Life Science market to help biotech entrepreneurs and executives take their innovative ideas to the next level.
read more
SSI Strategy announced that it has entered into a definitive agreement to acquire NDA Group AB, a regulatory affairs and drug development consultancy.
read more
The PPD clinical research business of Thermo Fisher Scientific was granted a five-year award to provide a Transplantation Statistical and Clinical Coordinating Center for the National Institute of Allergy and Infectious Diseases (NIAID), part of the ...
read more
Thursday, August 10, 2023
Phastar announced the appointment of Graham Clark as the new Chief Executive Officer. Amid ambitious growth plans and organizational changes, Clark will succeed Andrew MacGarvey as CEO and further boost the paradigm shift in delivery of world-class ...
read more
Thursday, August 10, 2023
X-Chem announced the addition of Karen Lackey as chief scientific officer (CSO) and David Hagerman as chief financial officer (CFO) to its global executive management team.
read more
Wednesday, August 09, 2023
Regeneron Pharmaceuticals and Decibel Therapeutics announced a definitive agreement for the acquisition of Decibel by Regeneron at a price of $4.00 per share of Decibel common stock payable in cash at closing, with an additional non-tradeable ...
read more
Wednesday, August 09, 2023
Emergent BioSolutions announced it is reducing investment in and de-emphasizing focus on growth in its CDMO services business. As a result, Emergent is reducing operations at its Bayview facility in Baltimore, Maryland.
read more
Wednesday, August 09, 2023
AGC Biologics announced the completion of its manufacturing space at its Milan Cell & Gene Center of Excellence production site.
read more
Wednesday, August 09, 2023
Ginkgo Bioworks announced a new collaboration with Merck focused on improving biologic manufacturing.
read more
Thursday, August 03, 2023
Celegence, a regulatory compliance service and software solution company, announced the launch of CAPTIS Copilot, the most advanced document automation and literature review solution for the life sciences industry.
read more
Thursday, August 03, 2023
TrialAssure, a software-as-a-service (SaaS) provider advancing clinical trial disclosure, data sharing, and transparency, announced that it is collaborating with MMS, a global clinical research organization, on a new artificial intelligence (AI) ...
read more
Thursday, August 03, 2023
Mind Medicine announced that it has entered into a license agreement with Catalent to access the company’s proprietary Zydis® orally disintegrating tablet (ODT) technology.
read more
Thursday, August 03, 2023
DNAnexus, a provider of cloud-based genomic and biomedical data access and companion analysis software, announced a collaboration with BigOmics Analytics, a Swiss biomedical data analysis company.
read more